PATIENT INFORMATION Patient Name DOB Allergies Shenya Jones 11/3/19XX Cinnamon,
ID: 138358 • Letter: P
Question
PATIENT INFORMATION Patient Name DOB Allergies Shenya Jones 11/3/19XX Cinnamon, peanuts Attending MRN Other Information Elizabeth Williams, MD 124-86-564 Wound C&S sent to Laboratory Services © McGraw-Hill Education Shenya Jones, a 34-year-old female, arrives at the office with a swelling and a red pustule on her face. She states the problem started 2 days ago as a small pimple near her nose. It became irritated, then became extremely swollen and painful overnight. Now, this morning there was yellow drainage noted at the site and the swelling has increased. The area of drainage is approximately 1 cm in diameter. The upper lip, side of the face, and nose are all swollen. She rates the pain in her face as 7 out of 10. The physician thinks the condition may be impetigo or methicillin-resistant Staphylococcus aureus (MRSA), a type of skin infection that is resistant to the common antibiotics used to treat it. Dr. Williams will culture the wound to find out what type of microorganisms are present and what specific antibiotics could be used to treat the infection.
What aseptic technique practices would be most important with this patient?
Who do these aseptic technique practices protect?
What needs to be done before Shenya is brought back into the exam room?
Explanation / Answer
Answer: Soft-tissue infections are common, generally of mild to modest severity, and are easily treated with a variety of agents. An etiologic diagnosis of simple cellulitis is frequently difficult and generally unnecessary for patients with mild signs and symptoms of illness.
Emerging antibiotic resistance among Staphylococcus aureus (methicillin resistance) and Streptococcus pyogenes (erythromycin resistance) are problematic, because both of these organisms are common causes of a variety of skin and soft-tissue infections and because empirical choices of antimicrobials must include agents with activity against resistant strains.
Patients who present to the hospital with severe infection or whose infection is progressing despite empirical antibiotic therapy should be treated more aggressively, and the treatment strategy should be based upon results of appropriate Gram stain, culture, and drug susceptibility analysis.
Related Questions
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.